The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday.
FDA to streamline approvals for generic biological drugs in latest move targeting health costs
Related Posts
-
Des Moines police arrest hit-and-run suspect after pursuit
A hit-and-run suspect led Des Moines police on a car chase and foot pursuit before…
-
‘Saturday, this gets very real’: Shutdown to cut off SNAP for 42 million Americans
With the government shutdown ongoing, SNAP benefits are set to stop, leaving millions of Americans…
-
Ankeny residents to vote on $130M bond for school upgrades
Ankeny residents will decide on a $130 million bond next week to fund expansions in…
-
LIST: Who’s running for Iowa governor in 2026
The field of candidates running to be Iowa’s next governor continues to grow. Here’s who…
Leave a Reply